TY - JOUR T1 - Mucoadhesive Drug Delivery Systems for Pediatric and Geriatric Patients AU - Singh, Inderbir AU - Rai, Arya AU - Rawat, Shristhi Sohan AU - Rathi, Ritu AU - Raina, Deepika AU - Odeku, Oluwatoyin A. PY - 2023 DA - October DO - 10.55262/fabadeczacilik.1279777 JF - Fabad Eczacılık Bilimler Dergisi JO - Fabad J Pharm Sci PB - FABAD Ankara Eczacılık Bilimleri Derneği WT - DergiPark SN - 1300-4182 SP - 561 EP - 584 VL - 48 IS - 3 LA - en AB - A mucoadhesive drug delivery system (MDDS) has been a smart approach to the delivery of drugs at the target site. In MDDS mucus membrane and type of polymer plays an important role in the mucoadhesion phenomenon. To explain the mechanism behind mucoadhesion, various theories have been proposed such as electronic, adsorption, wetting, diffusion, and fracture theory. MDDS has been beneficial to some special patients, preferably pediatric and geriatric. Several challenges such as taste masking, dose determination, dosage form spitting, target delivery, the bioavailability of the drug, adverse drug reaction, toxicity, etc. are faced while developing any delivery system for these special patient populations. Keeping these challenges in mind several researchers have attempted to design and formulate MDDS according to their convenience. The current review focuses on a basic overview of mucoadhesion, various theories of mucoadhesion, and mucoadhesive polymers. The later part of the review focuses on the MDDS for pediatric and geriatric patients with their significance. Various patented formulations and clinical trials going on for these populations have also been discussed. KW - mucoadhesive KW - pediatric KW - geriatric CR - Francois M, Snoeckx E, Putteman P, Wouters F, De Proost E, Delaet U, Peeters J, Brewster ME.,(2003). A mucoadhesive, cyclodextrin-based vaginal cream formulation of itraconazole. Aaps Pharmsci., 5(1):50-4. CR - Freerks, L.; Soulou, E.P.; Batchelor, H.; Klein, S.,( 2019). A review of GI conditions critical to oral drug absorption in malnourished children. Eur.J. Pharm. Biopharm., 137, 9-22.doi: 10.1016/j. ejpb.2019.02.001 UR - https://doi.org/10.55262/fabadeczacilik.1279777 L1 - https://dergipark.org.tr/tr/download/article-file/3070388 ER -